{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:53:08Z","timestamp":1760550788990},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41440-019-0247-1","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T09:03:58Z","timestamp":1552035838000},"page":"1186-1191","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism"],"prefix":"10.1038","volume":"42","author":[{"given":"Aya","family":"Saiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"issue":"Suppl 1","key":"247_CR1","doi-asserted-by":"publisher","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","volume":"54","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Omura M. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother. 2000;54(Suppl 1):83s\u201385s.","journal-title":"Biomed Pharmacother"},{"key":"247_CR2","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr.","year":"2003","unstructured":"Young WF Jr. Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment. Endocrinology. 2003;144:2208\u201313.","journal-title":"Endocrinology"},{"key":"247_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"247_CR4","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, et al. Long-term cardio and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98:4826\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"247_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u201385.","journal-title":"Arch Intern Med"},{"key":"247_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Task Force Committee on Primary Aldosteronism TJES. Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"issue":"5","key":"247_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"John W. Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:jc20154061.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"247_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253\u2013390.","journal-title":"Hypertens Res"},{"key":"247_CR9","unstructured":"Naruse M, Nishikawa T, Yanase T, Shibata H. Task Force members of the Committee of Primary Aldosteronism of Japan Endocrine Society. Consensus statement of diagnosis and treatment of primary aldosteronism in Japan. Folia Endocrinologica Japonica. 2016;92:20."},{"key":"247_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1507\/endocrj.EJ16-0337","volume":"64","author":"R Hayashi","year":"2017","unstructured":"Hayashi R, Tamada D, Murata M, Mukai K, Kitamura T, Otsuki M, et al. Saline Infusion Test highly associated with the incidence of cardio and cerebrovascular events in primary aldosteronism. Endocr J. 2017;64:507\u201313.","journal-title":"Endocr J"},{"key":"247_CR11","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","volume":"86","author":"D Hirohara","year":"2001","unstructured":"Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab. 2001;86:4292\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"247_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3803\/EnM.2016.31.2.277","volume":"31","author":"JH Kim","year":"2016","unstructured":"Kim JH, Park KS, Hong AR, Shin CS, Kim SY, Kim SW. Diagnostic role of captopril challenge test in Korean subjects with high aldosterone-to-renin ratios. Endocrinol Metab. 2016;31:277\u201383.","journal-title":"Endocrinol Metab"},{"key":"247_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","volume":"24","author":"K Komukai","year":"2010","unstructured":"Komukai K, Mochizuki S, Yoshimura M. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. 2010;24:687\u201398.","journal-title":"Fundam Clin Pharmacol"},{"key":"247_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/hr.2014.129","volume":"37","author":"C Nakama","year":"2014","unstructured":"Nakama C, Kamide K, Kawai T, Hongyo K, Ito N, Onishi M, et al. The influence of aging on the diagnosis of primary aldosteronism. Hypertens Res. 2014;37:1062\u20137.","journal-title":"Hypertens Res"},{"key":"247_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709\u201317.","journal-title":"N Engl J Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0247-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0247-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0247-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:32Z","timestamp":1684617632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0247-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0247-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}